Press release | 5th February 2009

The Immunovirology Division of the French Atomic Energy Agency Selects BioBook to Manage its Research Data

Guildford, UK, February 5 2009 – IDBS today announces that the Immunovirology Division of the French Atomic Energy Agency (Commissariat à l’Ènergie Atomique, CEA) has selected E-WorkBook for biology (BioBook) to capture, collate, analyze and share experimental data across its multi-user immunovirology research projects.

Managed by Roger Le Grand, CEA’s Immunovirology Division focuses on viral/host interactions and pathogenesis, and the design and evaluation of new therapeutic and preventative approaches of viral infections. CEA sought an experimental data management solution that allowed scientists to analyze data as soon as it is generated and share that information in the form of regular reports to collaborating researchers.

Isabelle Mangeot-Méderlé, Project Leader for CEA, commented: “BioBook helps us to record all aspects of our experimental research into virology, immunology and haematology, and manage and analyze data from multiple projects. BioBook captures all data produced for each project, including biological and serological data, cellular immune responses induced after vaccination or infection and viral loads after infection.” She added: “We didn’t find any other product that met all our requirements, such as capturing data and structuring it by project while accommodating multiple users. Other products also didn’t offer the ability to analyze data between projects.”

Neil Kipling, founder and CEO of IDBS, commented: “Conducting research into the interactions between viruses and the immune system is vital to discovering new treatments that fight diseases such as cancer and HIV. CEA Life Sciences’ research into preventative and therapeutic approaches to control and treat these conditions is highly valuable and IDBS is proud that the CEA Immunovirology Division chose BioBook to handle its complex multi-user multi-project experimental data.”

About IDBS

IDBS is a trusted provider of integrated data management software and service solutions to both the life science and non-life science industries. The company’s ActivityBase and E-WorkBook Suites provide gold standard chemistry and biology data support from target validation to GxP validated phases of the R&D process. The company supports long term relationships with the leading research organizations, maximizing the value of research data by enabling the capture, storage, sharing and use of data, while protecting intellectual property across the spectrum of research activities.

Headquartered in Guildford, UK, IDBS has worldwide coverage, with U.S. offices in California, New Jersey and Massachusetts, consultancy teams across Europe and a network which delivers IDBS products and advisory services across Asia. Founded in 1989, IDBS employs more than 170 people worldwide.

About IDBSContact us

More news

Webinar | November 30 | Managing the Journey from Process Development to Insight

In this session, you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how out-of-the box workflows and integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.

Read more

IDBS Polar Insight

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Read more

Skyland Analytics Acquisition

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.

Read more

IDBS Acquires Skyland Analytics

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.

Read more